COVID-19 Archives
Ascension St. Thomas, Tristar Health, Meharry Medical College, Vanderbilt Health issue joint statement on COVID-19
Oct. 20, 2020—The number of active COVID-19 cases in Tennessee is rising. In the 13 counties that comprise the Nashville Metropolitan Area, new cases have increased 50% over the last 2 weeks. We strongly urge everyone in Middle Tennessee, and all Tennesseans, to remain vigilant in their efforts to limit the spread of the virus by wearing masks, washing hands and staying socially distant — including not participating in large gatherings.
Clinical trial to test HIV drugs to treat COVID-19
Oct. 16, 2020—Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
Possible COVID-19 “decoy”
Oct. 15, 2020—It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection.
THA honors VUMC efforts in remdesivir distribution
Oct. 14, 2020—A team of pharmacists and physicians from Vanderbilt University Medical Center that this spring took on statewide distribution of remdesivir, an urgently needed investigational drug for severely ill patients hospitalized with COVID-19, has received the President’s Award from the Tennessee Hospital Association (THA).
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
Oct. 13, 2020—AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca.
Undiagnosed Diseases Network continues to excel despite pandemic
Oct. 8, 2020—Though the COVID-19 pandemic halted in-person patient visits at Undiagnosed Diseases Network (UDN) sites, including Vanderbilt University Medical Center’s, since March, groundbreaking behind-the-scenes work continues.
COVID patient’s heart-lung transplant is world’s first
Oct. 8, 2020—Vanderbilt University Medical Center has performed the world’s first dual heart-lung transplant of a COVID-19 patient.
StrategyShare2020 presents thought-provoking sessions
Oct. 7, 2020—Although the global COVID-19 pandemic forced StrategyShare2020 organizers to rapidly transform the event to an online-only format, there were no compromises in the quality and depth of the presentations, and more than 1,000 individuals registered to participate interactively, a record number for the annual event.
Caregivers discuss impacts of treating COVID-19 patients
Oct. 1, 2020—Taking care of patients critically ill with COVID-19 takes an emotional and physical toll on health care providers who say many of these patients are among the sickest they’ve ever encountered.
Cancer centers nationwide join to address the impact of COVID-19 pandemic on cancer prevention and treatment
Sep. 24, 2020—A consortium of 17 cancer centers in the United States, including Vanderbilt-Ingram Cancer Center, have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.
REDCap helps state of Washington scale up its testing capacity
Sep. 24, 2020—Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.
Questions, answers on flu season and COVID
Sep. 24, 2020—Infectious diseases specialist Thomas Talbot, MD, MPH, chief hospital epidemiologist at Vanderbilt University Medical Center, answers questions about the rapidly approaching U.S. flu season and how it might play into the COVID-19 pandemic.
